Yeast two-hybrid screening service Sign up for PNAS Online eTocs
Link: Info for AuthorsLink: Editorial BoardLink: AboutLink: SubscribeLink: AdvertiseLink: ContactLink: Sitemap Link: PNAS Home
Proceedings of the National Academy of Sciences
Link: Current Issue "" Link: Archives "" Link: Online Submission ""  Link: Advanced Search

Published online on July 29, 2005, 10.1073/pnas.0501432102
PNAS | August 9, 2005 | vol. 102 | no. 32 | 11545-11550


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supporting Information
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prasad, H. C.
Right arrow Articles by Blakely, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prasad, H. C.
Right arrow Articles by Blakely, R. D.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg  
What's this?

 Previous Article  | Table of Contents |  Next Article 

NEUROSCIENCE
Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase

Harish C. Prasad *, Chong-Bin Zhu *, Jacob L. McCauley {dagger}, Devadoss J. Samuvel {ddagger}, Sammanda Ramamoorthy {ddagger}, Richard C. Shelton *, §, ¶, William A. Hewlett *, §, James S. Sutcliffe {dagger}, ¶, ||, and Randy D. Blakely *, §, ¶, **

Departments of *Pharmacology, {dagger}Molecular Physiology and Biophysics, and §Psychiatry, and Centers for ||Human Genetics Research and Molecular Neuroscience, Vanderbilt University School of Medicine, Nashville, TN 37232-8548; and {ddagger}Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425

Edited by Susan G. Amara, University of Pittsburgh School of Medicine, Pittsburgh, PA and approved June 8, 2005 (received for review February 19, 2005)

Human serotonin [5-hydroxytryptamine (5-HT)] transporters (hSERT, 5HTT, and SLC6A4) inactivate 5-HT after release and are prominent targets for therapeutic intervention in mood, anxiety, and obsessive-compulsive disorders. Multiple hSERT coding variants have been identified, although to date no comprehensive functional analysis of these variants has been reported. We transfected hSERT or 10 hSERT coding variants and examined total and surface protein expression, antagonist recognition, and transporter modulation by posttranslational, regulatory pathways. Two variants, Pro339Leu and Ile425Val, demonstrated significant changes in surface expression supporting alterations in 5-HT transport capacity (Vmax). Regardless of basal transport activity, all SERT variants displayed a capacity for rapid, phorbol ester-triggered down-regulation. Remarkably, five variants (Thr4Ala, Gly56Ala, Glu215Lys, Lys605Asn, and Pro612Ser) demonstrated no capacity for 5-HT uptake stimulation after acute protein kinase G (PKG)/p38 mitogen-activated protein kinase (MAPK) activation. Epstein–Barr virus (EBV)-transformed lymphocytes natively expressing the most common of these variants (Gly56Ala) exhibited a similar loss of 5-HT uptake stimulation by PKG/p38 MAPK activators. HeLa cells transfected with the Gly56Ala variant demonstrated elevated basal phosphorylation and, unlike hSERT, could not be further phosphorylated after 8-bromo cGMP (8BrcGMP) treatments. These studies reveal cellular phenotypes associated with naturally occurring human SERT coding variants and suggest that altered transporter regulation by means of PKG/p38 MAPK-linked pathways may influence risk for disorders attributed to compromised 5-HT signaling.

transport | antidepressant | polymorphism | regulation | autism

Author contributions: H.C.P., J.L.M., D.J.S., and S.R. performed research; H.C.P., J.L.M., D.J.S., S.R., J.S.S., and R.D.B. analyzed data; H.C.P., C.-B.Z., D.J.S., S.R., and R.D.B. designed research; J.L.M., D.J.S., S.R., and J.S.S. contributed new reagents/analytic tools; and H.C.P., C.-B.Z., J.L.M., D.J.S., S.R., R.C.S., W.A.H., J.S.S., and R.D.B. wrote the paper.

This paper was submitted directly (Track II) to the PNAS office.

Abbreviations: 5-HT, 5-hydroxytryptamine; SERT, serotonin transporter; hSERT, human SERT; PKG, protein kinase G; MAPK, mitogen-activated protein kinase; OCD, obsessive-compulsive disorder; TM, transmembrane domain; 8BrcGMP, 8-bromo cGMP; {beta}-PMA, {beta}-phorbol 12-myristate 13-acetate; RTI-55, (3{beta}-(4-iodophenyl)tropan-2{beta}-carboxylic acid methyl ester.

** To whom correspondence should be addressed at: Vanderbilt Center for Molecular Neuroscience, Suite 7140, MRBIII, Vanderbilt School of Medicine, Nashville, TN 37232-8548. E-mail: randy.blakely{at}vanderbilt.edu.

© 2005 by The National Academy of Sciences of the USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg    What's this?


This article has been cited by other articles in HighWire Press-hosted journals:


Home page
 Hum Mol GenetHome page
J. R. Wendland, P. R. Moya, M. R. Kruse, R. F. Ren-Patterson, C. L. Jensen, K. R. Timpano, and D. L. Murphy
A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder
Hum. Mol. Genet., March 1, 2008; 17(5): 717 - 723.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. R. Bruchas, B. B. Land, M. Aita, M. Xu, S. K. Barot, S. Li, and C. Chavkin
Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates {kappa}-Opioid-Dependent Dysphoria
J. Neurosci., October 24, 2007; 27(43): 11614 - 11623.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
Y.-W. Zhang, J. Gesmonde, S. Ramamoorthy, and G. Rudnick
Serotonin Transporter Phosphorylation by cGMP-Dependent Protein Kinase Is Altered by a Mutation Associated with Obsessive Compulsive Disorder
J. Neurosci., October 3, 2007; 27(40): 10878 - 10886.
[Abstract] [Full Text] [PDF]

Home page
 CSHL ProtocolsHome page
A. Sahota, A. I. Brooks, and J. A. Tischfield
Preparing DNA from Mammalian Sources for Genotyping
CSH Protocols, July 1, 2007; 2007(16): pdb.top19 - pdb.top19.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
S. Ramamoorthy, D. J. Samuvel, E. R. Buck, G. Rudnick, and L. D. Jayanthi
Phosphorylation of Threonine Residue 276 Is Required for Acute Regulation of Serotonin Transporter by Cyclic GMP
J. Biol. Chem., April 20, 2007; 282(16): 11639 - 11647.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Dipace, U. Sung, F. Binda, R. D. Blakely, and A. Galli
Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes
Mol. Pharmacol., January 1, 2007; 71(1): 230 - 239.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. D. Jayanthi, B. Annamalai, D. J. Samuvel, U. Gether, and S. Ramamoorthy
Phosphorylation of the Norepinephrine Transporter at Threonine 258 and Serine 259 Is Linked to Protein Kinase C-mediated Transporter Internalization
J. Biol. Chem., August 18, 2006; 281(33): 23326 - 23340.
[Abstract] [Full Text] [PDF]